title: Results of sclerotherapy in 100 patients comparison of the outcome between schistosomiasis and hepatitis B.
abstract: One hundred patients received sclerotherapy for acutely bleeding esophageal varices. Seventy per cent of these patients had chronic liver disease due to schistosomiasis or hepatitis B. The remaining 30% had chronic liver disease of other etiology, including alcohol in 2%. Our study shows a favorable outcome of sclerotherapy in the schistosomal group during a mean follow-up period of 39 months. Esophageal varices were completely sclerosed in 53.3% of schistosoma patients, in 37.5% of hepatitis B, and in 42.3% of other groups. The rebleeding rate was 11.1% in schistosomiasis, 43.8% in hepatitis B and 33.3% in other groups. The overall mortality rate was 4.4% in the schistosomal group, 50.0% in the hepatitis B, and 40% in other groups. Rebleeding from gastric varices occurred in 17 patients, 13 of whom died, including 11 who were operated on for bleeding gastric varices and died following surgery.
authors.affiliation: Division of Gastroenterology, Armed Forces Hospital, Riyadh, Kingdom of Saudi Arabia.
authors.forename: A E
authors.initials: AE
authors.lastname: Mohamed
authors.forename: M A
authors.initials: MA
authors.lastname: al Karawi
authors.forename: R
authors.initials: R
authors.lastname: al Otaibi
authors.forename: M A
authors.initials: MA
authors.lastname: Hanid
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D004932:Esophageal and Gastric Varices / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000150:complications* / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012529:Saudi Arabia / Q000453:epidemiology; D012552:Schistosomiasis / Q000150:complications* / Q000401:mortality; D015911:Sclerotherapy